Life Sciences Data Centres
Kao Data meeting Life Sciences big data infrastructure needs
Described as the “beating heart of research and science in the UK today”, Cambridge and its’ surrounding area has established itself as a world-class location for the Life Sciences sector. With its’ historic university at its core the area hosts more than 3,500 companies. From start-ups to global giants with state of the art R&D centres as well as global headquarters. Employing tens of thousands of people with market capitalisation measured in the billions of pounds, as a high-tech business cluster – it is one of the fastest growing economic regions in the UK.
Life Science is a data intensive sector. Whether working on the human genome, creating personalised healthcare and bespoke drugs, pushing advances in intelligent automation, robotics in healthcare, biologics, sensorial health monitoring, applying artificial intelligence and smart algorithms to devices to prevent heart disease and strokes, companies from right across the Life Sciences sector are generating and analysing vast pools of data. Industry forecasts suggest that Life Science companies will evolve beyond owning physical assets to becoming data companies. Data sharing is becoming more widespread with many companies now operating in ecosystems, technologies such as Blockchain are being used to transmit contracts and exchange data between ecosystem partners, speeding research and extending collaboration.
Security and Scale
Few data sets are as precious as health information. It is a sector where security, and data integrity are vital. For example, data handling from drug development stages like discovery, product characterization, formulation, bio analytical tests and clinical trials must be captured, stored and transported using the highest possible cybersecurity methods.
Life Sciences companies are addressing big data challenges. Research centres are operating on premise data centres combined with third-party off site facilities. Trusted networks to support big computation have been established between different national and international research institutes. Big Data is a new opportunity to base all of these around shared data resources – data sharing strategies are becoming common.
According to the report; The Digitalization of the Life Sciences Sector from KPMG: “The benefits of data generated by sensors, devices, and other technologies for the life sciences companies are obvious. If companies are able to create comprehensive client journeys, the path leads from supplying a single drug to providing individualized, holistic health solutions. As a result, life sciences companies or disruptive new entrants could play an integral part throughout patients’ lives”.
Life Sciences Digital Strategies
The huge amounts of data being generated and shared in bio analytics, cancer treatment and research, genome mapping and new healthcare techniques are driving the requirement for modern data centre facilities. Just over 20 miles from Cambridge, Kao Data Campus is ideally positioned to serve the UK’s life sciences sector – providing secure, resilient and sustainable IT infrastructure services. Fully optimised and designed to cater for high-density workloads, the Kao Data London One facility incorporates industry-leading technology with the highest levels of reliability expected from a world-class service provider. Kao Data’s flexible approach ensures that capacity will be available to our customers when needed, allowing them to rapidly scale their existing footprints. Technical space can also be reserved in advance to ensure that all systems are located together as workload requirements grow. With ease of access by rail or road, the campus also has the availability of on-site parking, as well as dedicated meeting spaces.